Dexa Group - Full Product List
Product Description
Dexa Medica
-
Country/Region:Indonesia
-
On CPHI since:2020
-
Certificates:3
-
Employees:5000+
Company types
Primary activities
Dexa Medica
-
Country/Region:Indonesia
-
On CPHI since:2020
-
Certificates:3
-
Employees:5000+
Company types
Primary activities
More Products from Dexa Medica (15)
-
Product Gemcitabine 200, 1000
PT. Fonko international Pharmaceuticals offers a wide range of oncology finished dosage which includes Gemcitabine 200 mg, 1000 mg. Indication : Locally advance or metastatic bladder cancer, metastatic adenocarcinoma of the pancreas, advanced or metastatic non-small cell lung cancer (NSCLC), locally ... -
Product Oxaliplatin 50, 100
PT. Fonko international Pharmaceuticals offers a wide range of oncology finished dosage which includes Oxaliplatin 50 mg. Indication : Stage III colon cancer (Duke's C) and metastatic colorectal cancer. Contact us for more information -
Product Paclitaxel 30, 100, 300
PT. Fonko international Pharmaceuticals offers a wide range of oncology finished dosage which includes Paclitaxel 30 mg, 100 mg and 300 mg. Indication : Ovarian carcinoma, Breast carcinoma, Advanced non-small cell lung carcinoma, AIDS-related Kaposi's sarcoma. Contact us for more information -
Product Pemetrexed 100, 500
PT. Fonko international Pharmaceuticals offers a wide range of oncology finished dosage which includes Pemetrexed 100 mg, 500 mg. Indication : Malignant pleural mesothelioma, non-small cell lung cancer. Contact us for more information -
Product Vinorelbine 10
PT. Fonko international Pharmaceuticals offers a wide range of oncology finished dosage which includes Vinorelbine 10 mg. Indication : non-small cell lung cancer and breast cancer, Contact us for more information -
Product Dexa Group - Evidenced based natural medicines
https://www.dexagroup.com/advanced-herbal-medicines/ -
Product Bendamustine 25, 100
PT. Fonko international Pharmaceuticals offers a wide range of oncology finished dosage which includes Bendamustine 25 mg and 100 mg. Indication : Chronic lymphocytic Leukemia, Non-Hodgin Lymphoma and Multiple Myeloma. Contact us for more information -
Product Bortezomib 1, 3.5
PT. Fonko international Pharmaceuticals offers a wide range of oncology finished dosage which includes Bortezomib 1 mg, 3.5 mg Indication : multiple myeloma, mantle cell lymphoma. Contact us for more information -
Product Carboplatin 150, 450
PT. Fonko international Pharmaceuticals offers a wide range of oncology finished dosage which includes Carboplatin 150 mg, 450 mg. Indication : Initial treatment of advance ovarian carcinoma, Secondary treatment of advance ovarian carcinoma. Contact us for more information -
Product Cisplatin 10, 50
PT. Fonko international Pharmaceuticals offers a wide range of oncology finished dosage which includes Cisplatin 10 mg, 50 mg. Indication : Metastatic testicular tumors or metastatic ovarian tumors and advanced bladder cancer. Contact us for more information -
Product Cyclophosphamide 200, 500, 1000
PT. Fonko international Pharmaceuticals offers a wide range of oncology finished dosage which includes Cyclophosphamide 200 mg, 500 mg and 1000 mg. Indication : Leukemia, lymphogranulomatosis, lymphosarcoma, retinothelial sarcoma, multiple myeloma, Breast Cancer, Ovarian Cancer. Contact us for more i... -
Product DLBS Products
Beyond Botanicals : DLBS Innovation in Evidence-Based Herbal Medicine
A relaxed evening where you can connect with our team and fellow partners over drinks and light bites, which relate to Herbal Medicine.
Event Details:
Date : Tue, 28 Oct 2025
Time : 6.00 – 7.30 PM
...
